Project description
Novel therapeutic targets in epilepsy
Epilepsy is a neurological condition that is characterised by seizures. Current therapies are ineffective in nearly 30 % of patients, necessitating the development of novel treatments. The EU-funded EpiPurines project is focusing on the purinergic signalling system, which is activated by nucleotides and nucleosides. Using disease animal models and induced pluripotent stem cells, scientists will investigate the outcome of targeting various receptors and enzymes implicated in the system's pathways. Results will help us understand the role of purinergic signalling in epileptogenesis and pave the way for new drugs that offer improved seizure control and suppression of epilepsy.
Fields of science
Programme(s)
Funding Scheme
MSCA-IF-GF - Global Fellowships
Coordinator
2 Dublin
Ireland
See on map
Partners (1)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
08901 New Brunswick
See on map